April 18, 2024
An avid world traveler, Sophia Agnihotri knew something was wrong when she started experiencing uncontrollable shaking and extreme fatigue. Her symptoms made it difficult to do daily tasks and ultimately led her to quit her job. After being diagnosed with Parkinson's disease, she found relief and new hope through treatment by Mya Schiess, MD, at UTHealth Houston.
April 12, 2024
Assistant Professor Paula Cuccaro, PhD; Professor Ross Shegog, PhD; and Associate Professor Lara Savas, PhD, were awarded $3,996,163 from the Cancer Prevention and Research Institute of Texas (CPRIT) to develop adolescent cancer prevention research. These awards were part of a $100 million grant to continue Texas's initiatives to build cancer research and represent the country's most significant state initiative to combat cancer.
April 8, 2024
The Department of Obstetrics, Gynecology, and Reproductive Sciences at McGovern Medical School at UTHealth Houston recently achieved accreditation from the Surgical Review Corporation (SRC) as a Center of Excellence. This accreditation recognizes the department’s commitment and high standard of patient care and safety.
March 26, 2024
Delaying surgical inguinal hernia repair in preterm infants until after discharge from the neonatal intensive care unit (NICU) appears to reduce the likelihood of serious adverse events, according to researchers at UTHealth Houston.
March 25, 2024
In the two years since the John S. Dunn Behavioral Sciences Center at UTHealth Houston opened its doors in collaboration with the Texas Health and Human Services Commission (HHSC), it has helped relieve the overall wait times for Texans needing mental health care and provided a resource closer to home for patients.
March 13, 2024
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
March 13, 2024
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
March 6, 2024
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.
March 5, 2024
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
February 27, 2024
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
